. Author manuscript; available in PMC: 2016 Jul 1.

Published in final edited form as: Pediatr Crit Care Med. 2015 Jul;16(6):529–534. doi: 10.1097/PCC.0000000000000408

Table 3.

NT-proBNP levels (pg/ml)^* at D0, D2 and D7

	All patients (n=16)	CV outcome (n=6)	No CV outcome (n=10)	p value
NT-proBNP Day 0	5,578 (2,952–14,591)	13,150 (7,865–15,274)	4,425 (1,637–6,392)	0.10
NT-pro BNP Day 2	3,581 (1,707–6,205)	5,329 (4,382–13,981)	2,147 (866–3,574)	0.07
NT-pro BNP Day 7	3,226 (642–7,610)	7,365 (4613–14,333)	1,196 (313–3,084)	0.02
NT-pro BNP percent decline Day 2	48 (36–57)	34 (33–60)	49 (40–56)	0.45
NT-pro BNP percent decline Day 7	62 (35–75)	28.5 (−7–51)	73 (61–79)	0.02

Values expressed as median (25 and 75th percentiles). Comparisons by Mann-Whitney U test